Clinical Trial Update: Clinical Outcomes, Compliance and Effectiveness of Switching From Infliximab or Etanercept to Adalimumab in Patients With Active Rheumatoid Arthritis (RA). A Multicenter Post-Marketing Observational Study in Routine Clinical Use

View source ↗

Summary

This multicenter post-marketing observational study assesses outcomes, adherence, and effectiveness after switching rheumatoid arthritis patients from inflixima…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)
• Etanercept (etanercept)
• Infliximab (infliximab)

Snippet

Sponsor: Abbott | Conditions: Rheumatoid Arthritis | Status: TERMINATED | Results posted: 2012-01-02